Jeffrey C. Flynn

Learn More
To improve the efficacy of immunotherapy for cancer and autoimmune diseases, recent ongoing and completed clinical trials have focused on specific targets to redirect the immune network toward eradicating a variety of tumors and ameliorating the self-destructive process. In a previous review, both systemic immunomodulators and monoclonal antibodies (mAbs),(More)
Literature relevant to the relationship between early ingestion of inorganic lead and subsequent hyperactivity in rodents is discussed. Original research in the area is presented. Rats so exposed were not hyperactive in any of the situations investigated or under any of the dosage regimens employed. They did show hypoactivity in the open field when dosed(More)
  • 1